rs397515744

Variant summary

Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM1PM2PP3_Strong

The NM_000116.5(TAFAZZIN):​c.535C>A​(p.Pro179Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 24)

Consequence

TAFAZZIN
NM_000116.5 missense

Scores

10
6
1

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 7.25
Variant links:
Genes affected
TAFAZZIN (HGNC:11577): (tafazzin, phospholipid-lysophospholipid transacylase) This gene encodes a protein that is expressed at high levels in cardiac and skeletal muscle. Mutations in this gene have been associated with a number of clinical disorders including Barth syndrome, dilated cardiomyopathy (DCM), hypertrophic DCM, endocardial fibroelastosis, and left ventricular noncompaction (LVNC). Multiple transcript variants encoding different isoforms have been described. A long form and a short form of each of these isoforms is produced; the short form lacks a hydrophobic leader sequence and may exist as a cytoplasmic protein rather than being membrane-bound. Other alternatively spliced transcripts have been described but the full-length nature of all these transcripts is not known. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 8 ACMG points.

PM1
In a region_of_interest Mitochondrial targeting sequence (size 35) in uniprot entity TAZ_HUMAN there are 4 pathogenic changes around while only 0 benign (100%) in NM_000116.5
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.989

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TAFAZZINNM_000116.5 linkuse as main transcriptc.535C>A p.Pro179Thr missense_variant 6/11 ENST00000601016.6 NP_000107.1 Q16635-1A0A0S2Z4K0

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TAFAZZINENST00000601016.6 linkuse as main transcriptc.535C>A p.Pro179Thr missense_variant 6/111 NM_000116.5 ENSP00000469981.1 Q16635-1

Frequencies

GnomAD3 genomes
Cov.:
24
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
24

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.99
BayesDel_addAF
Pathogenic
0.70
D
BayesDel_noAF
Pathogenic
0.77
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.93
.;.;.;.;D;.;D
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Uncertain
0.89
D;D;.;D;T;D;D
M_CAP
Pathogenic
0.96
D
MetaRNN
Pathogenic
0.99
D;D;D;D;D;D;D
MetaSVM
Pathogenic
1.0
D
MutationAssessor
Pathogenic
3.8
.;H;.;.;H;.;.
PrimateAI
Uncertain
0.68
T
PROVEAN
Pathogenic
-7.2
.;.;.;.;.;D;D
REVEL
Pathogenic
0.97
Sift
Uncertain
0.0070
.;.;.;.;.;D;D
Sift4G
Uncertain
0.0080
D;D;D;D;D;D;D
Polyphen
0.95
P;P;.;P;D;.;.
Vest4
0.86
MutPred
0.88
.;Loss of methylation at K182 (P = 0.0865);.;.;Loss of methylation at K182 (P = 0.0865);.;.;
MVP
1.0
ClinPred
1.0
D
GERP RS
5.5
RBP_binding_hub_radar
0.92
RBP_regulation_power_radar
2.6
Varity_R
0.82
gMVP
1.0

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chrX-153647956; API